BRIEF published on 04/29/2024 at 07:48, 1 year 10 months ago Deufol SE annonce de solides performances dans ses résultats annuels 2023 Croissance Financière Résultats Annuels 2023 Expansion Mondiale Répartition Des Dividendes Deufol SE
PRESS RELEASE published on 04/29/2024 at 07:43, 1 year 10 months ago Deufol SE: Annual Results 2023 Deufol SE reports solid organic growth and profitable global expansion in 2023 with sales reaching €294.0 million and EBITDA of €46.1 million. The company strengthens market presence and increases customer loyalty Global Expansion EBITDA Organic Growth Market Presence Deufol SE
PRESS RELEASE published on 05/24/2023 at 08:52, 2 years 10 months ago Deufol SE: Settlement reached with former managers to resolve long-standing legal disputes / Resumption of dividend payment proposed
PRESS RELEASE published on 04/28/2023 at 09:59, 2 years 10 months ago Deufol SE: Results for the business year 2022
Published on 03/26/2026 at 21:00, 4 minutes ago Worksport Reports Record FY 2025 Results, Issues $35M–$42M 2026 Revenue Guidance; Targets Initial Cash Flow Positivity
Published on 03/26/2026 at 16:20, 4 hours 44 minutes ago ACCESS Newswire Upgrades the ACCESS Platform to Include Social Monitoring to Track Brand Conversations Across Major Social Platforms
Published on 03/26/2026 at 13:00, 8 hours 4 minutes ago Prospect Ridge Strengthens Technical Team with Appointment of Phil Smerchanski as Senior Technical Advisor
Published on 03/26/2026 at 13:00, 8 hours 4 minutes ago GameSquare's Stream Hatchet Launches Creator Communities to Manage the Full Creator Marketing Lifecycle
Published on 03/26/2026 at 20:48, 16 minutes ago Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer
Published on 03/26/2026 at 19:20, 1 hour 44 minutes ago Critical Path Institute Launches 'One to Millions' to Reshape the Future of Individualized Medicine at Global Scale
Published on 03/26/2026 at 19:09, 1 hour 55 minutes ago 2CRSi SA: Résultats 1er Semestre 2025/26 : Chiffre d'Affaires 204,7 M€ (x9,8) EBITDA de 9,6 M€ (x4,6)
Published on 03/26/2026 at 19:09, 1 hour 55 minutes ago 2CRSi SA: First Half 2025/26 Results: Revenue of €204.7 million (x9.8) EBITDA of €9.6 million (x4.6)
Published on 03/26/2026 at 18:17, 2 hours 47 minutes ago Eiffage se renforce au capital de Getlink et porte sa participation à 29,40 % du capital
Published on 03/26/2026 at 18:17, 2 hours 47 minutes ago Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 18:00, 3 hours 4 minutes ago Arrêté des comptes au 31 décembre 2025 et perspectives 2026
Published on 03/26/2026 at 18:00, 3 hours 4 minutes ago LABORATOIRES EUROMEDIS - Fin du contrat de liquidité
